CoChat
Sign Up
Cited by 88

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

In vivo effects: Methodologies and biokinetics of inhaled nanomaterials

Oberdörster, Günter, Kuhlbusch, Thomas A.J.·2018·NanoImpact
DOI 10.1016/j.impact.2017.10.007
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.impact.2017.10.007

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Figures

Image 1
CC-BY-NC-ND · From the PDF
Image 2
CC-BY-NC-ND · From the PDF
Image 3
CC-BY-NC-ND · From the PDF
Fig. 3 Estimation of chronic NOAEC from subchronic rodent study using MPPD modelling of experimentally determined subchronic NOAEC and associated NOAEL. (Modi fi ed from Oberdörster, 2002.)
Fig. 3 Estimation of chronic NOAEC from subchronic rodent study using MPPD modelling of experimentally determined subchronic NOAEC and associated NOAEL. (Modi fi ed from Oberdörster, 2002.)CC-BY-NC-ND · From the PDF
Fig. 4 Examples of cell-free (acellular) assays determining ROS activity.
Fig. 4 Examples of cell-free (acellular) assays determining ROS activity.CC-BY-NC-ND · From the PDF
Image 6
CC-BY-NC-ND · From the PDF
Fig. 6 Correlation of in vivo pulmonary in fl ammation and cell-free in vitro ROS activity expressed per unit particle surface.
Fig. 6 Correlation of in vivo pulmonary in fl ammation and cell-free in vitro ROS activity expressed per unit particle surface.CC-BY-NC-ND · From the PDF
Fig. 7 ROS/cm 2 response of anatase TiO2 in cell free assay as function of particle size showing that the surface reactivity can be size-dependent.
Fig. 7 ROS/cm 2 response of anatase TiO2 in cell free assay as function of particle size showing that the surface reactivity can be size-dependent.CC-BY-NC-ND · From the PDF
Image 9
CC-BY-NC-ND · From the PDF
Fig. 9 Determinants of pulmonary biopersistence of inhaled particles.
Fig. 9 Determinants of pulmonary biopersistence of inhaled particles.CC-BY-NC-ND · From the PDF
Image 11
CC-BY-NC-ND · From the PDF
Concept: The same normalized retained lung dose in rats after acute, subchronic or chronic inhalation of poorly soluble particles is reached by humans exposed to the HEC. Effects may be different for both species.
Concept: The same normalized retained lung dose in rats after acute, subchronic or chronic inhalation of poorly soluble particles is reached by humans exposed to the HEC. Effects may be different for both species.CC-BY-NC-ND · From the PDF
Fig. 12 Approach for deriving ρ e ff in vivo using a 4-h rat inhalation study with aerosols of agglomerated/aggregated nanoparticles.
Fig. 12 Approach for deriving ρ e ff in vivo using a 4-h rat inhalation study with aerosols of agglomerated/aggregated nanoparticles.CC-BY-NC-ND · From the PDF
Fig. 13 Concept of estimating in vivo dissolution of NPs: Accumulation in rat lungs of inhaled SiO2 NPs established in 4-week inhalation study; (4 h/day; 5 days/week; 4 weeks; conc 4.6 mg/m 3 ; MMAD = 0.49 μ m; GSD = 1.91); comparison to modelled accumulation of inhaled PSP with same aerosol and exposure characteristics. The di ff erence in clearance rates between SiO2 and PSP is due to dissolution of SiO2 NPs.
Fig. 13 Concept of estimating in vivo dissolution of NPs: Accumulation in rat lungs of inhaled SiO2 NPs established in 4-week inhalation study; (4 h/day; 5 days/week; 4 weeks; conc 4.6 mg/m 3 ; MMAD = 0.49 μ m; GSD = 1.91); comparison to modelled accumulation of inhaled PSP with same aerosol and exposure characteristics. The di ff erence in clearance rates between SiO2 and PSP is due to dissolution of SiO2 NPs.CC-BY-NC-ND · From the PDF
Fig. 14 Approach for comparative hazard and risk characterization of inhaled nanoparticles based on subchronic (3 months) rat inhalation studies. NOAEL : no observed adverse effect level ; BMD : benchmark dose ; OEL : occupational exposure level ; ATS : alternative testing strategy .
Fig. 14 Approach for comparative hazard and risk characterization of inhaled nanoparticles based on subchronic (3 months) rat inhalation studies. NOAEL : no observed adverse effect level ; BMD : benchmark dose ; OEL : occupational exposure level ; ATS : alternative testing strategy .CC-BY-NC-ND · From the PDF
Fig. 15 In vitro -in vivo dosimetric extrapolation in nanotoxicology for respiratory tract exposures (modi fi ed from Oberdörster et al., 2015). VCM: Volumetric Centrifugation Method (DeLoid et al., 2014). ISDD: In vitro Sedimentation, Di ff usion, Dosimetry: (Hinderliter et al., 2010), DG: Distorted Grid (soluble): (DeLoid et al., 2015), MPPD: Multiple Path Particle Dosimetry: (Miller et al., 2016).
Fig. 15 In vitro -in vivo dosimetric extrapolation in nanotoxicology for respiratory tract exposures (modi fi ed from Oberdörster et al., 2015). VCM: Volumetric Centrifugation Method (DeLoid et al., 2014). ISDD: In vitro Sedimentation, Di ff usion, Dosimetry: (Hinderliter et al., 2010), DG: Distorted Grid (soluble): (DeLoid et al., 2015), MPPD: Multiple Path Particle Dosimetry: (Miller et al., 2016).CC-BY-NC-ND · From the PDF
Image 17
CC-BY-NC-ND · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 121

  1. Arts, 2014, A critical appraisal of existing concepts for the grouping of nanomaterials, Regul. Toxicol. Pharmacol., 70, 492, 10.1016/j.yrtph.2014.07.025 · DOI
  2. Bachler, 2013, A physiologically based pharmacokinetic model for ionic silver and silver nanoparticles, Int. J. Nanomedicine, 8, 3365
  3. Baisch, 2014, Equivalent titanium dioxide nanoparticle deposition by intratracheal instillation and whole body inhalation: the effect of dose rate on acute respiratory tract inflammation, Part. Fibre Toxicol., 11, 5, 10.1186/1743-8977-11-5 · DOI
  4. Balasubramanian, 2013, The effect of primary particle size on biodistribution of inhaled gold nano-agglomerates, Biomaterials, 34, 5439, 10.1016/j.biomaterials.2013.03.080 · DOI
  5. Bernstein, 2005, Comparison of Calidria Chrysotile Asbestos to pure Tremolite: final results of the inhalation biopersistence and histopathology examination following short-term exposure, Inhal. Toxicol., 17, 427, 10.1080/08958370591002012 · DOI · Paper page
  6. Bello, 2009, Nanomaterials properties vs. biological oxidative damage: implications for toxicity screening and exposure assessment, Nanotoxicology, 3, 249, 10.1080/17435390902989270 · DOI
  7. Bermudez, 2004, Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles, Toxicol. Sci., 77, 347, 10.1093/toxsci/kfh019 · DOI · Paper page
  8. Braakhuis, 2016, Identification of the appropriate dose metric for pulmonary inflammation of silver nanoparticles in an inhalation toxicity study, Nanotoxicology, 10, 63
  9. Buesen, 2014, Effects of SiO2, ZrO2, and BaSO4 nanomaterials with or without surface functionalization upon 28-day oral exposure to rats, Arch. Toxicol., 88, 1881, 10.1007/s00204-014-1337-0 · DOI
  10. Calderon-Garciduenas, 2004, Brain inflammation and Alzheimer's-like pathology in individuals exposed to severe air pollution, Toxicol. Pathol., 32, 650, 10.1080/01926230490520232 · DOI
  11. Campagnolo, 2017, Silver nanoparticles inhaled during pregnancy reach and affect the placenta and the foetus, Nanotoxicology, 11, 687, 10.1080/17435390.2017.1343875 · DOI
  12. Charvet, 2014, Characterizing the effective density and primary particle diameter of airborne nanoparticles produced by spark discharge using mobility and mass measurements (tandem DMA/APM), J. Nanopart. Res., 16
  13. Charvet, 2015, On the importance of density in ELPI data post-treatment, Aerosol Sci. Technol., 49, 1263, 10.1080/02786826.2015.1117568 · DOI
  14. Cho, 2013, Predictive value of in vitro assays depends on the mechanism of toxicity of metal oxide nanoparticles, Part. Fibre Toxicol., 10, 55, 10.1186/1743-8977-10-55 · DOI
  15. DeLoid, 2014, Estimating the effective density of engineered nanomaterials for in vitro dosimetry, Nat. Commun., 5, 3514, 10.1038/ncomms4514 · DOI · Paper page
  16. DeLoid, 2015, Advanced computational modeling for in vitro nanomaterial dosimetry, Part. Fibre Toxicol., 12, 32, 10.1186/s12989-015-0109-1 · DOI
  17. DeLoid, 2017, Preparation, characterization, and in vitro dosimetry of dispersed, engineered nanomaterials, Nat. Protoc., 12, 355, 10.1038/nprot.2016.172 · DOI
  18. DeLorme, 2012, Ninety-day inhalation toxicity study with a vapor grown carbon nanofiber in rats, Toxicol. Sci., 128, 449, 10.1093/toxsci/kfs172 · DOI
  19. Drasler, 2017, In vitro approaches to assess the hazard of nanomaterials, NanoImpact, 10.1016/j.impact.2017.08.002 · DOI
  20. Drew, 2017, A quantitative framework to group nanoscale and microscale particles by hazard potency to derive occupational exposure limits: proof of concept evaluation, Regul. Toxicol. Pharmacol., 89, 253, 10.1016/j.yrtph.2017.08.003 · DOI
  21. Driscoll, 2000, Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: uses and limitations, Toxicol. Sci., 55, 24, 10.1093/toxsci/55.1.24 · DOI · Paper page
  22. Duffin, 2007, Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity, Inhal. Toxicol., 19, 849, 10.1080/08958370701479323 · DOI · Paper page
  23. Eastes, 2000, Estimation of dissolution rate from in vivo studies of synthetic vitreous fibers, Inhal. Toxicol., 12, 1037, 10.1080/08958370050164644 · DOI
  24. Elder, 2006, Translocation of inhaled ultrafine manganese oxide particles to the central nervous system, Environ. Health Perspect., 114, 1172, 10.1289/ehp.9030 · DOI
  25. Gangwal, 2011, Informing selection of nanomaterial concentrations for ToxCast in vitro testing based on occupational exposure potential, Environ. Health Perspect., 119, 1539, 10.1289/ehp.1103750 · DOI
  26. Gao, 2017, Progress towards standardized and validated characterizations for measuring physicochemical properties of manufactured nanomaterials relevant to nano-EHS, NanoImpact
  27. Geraets, 2014, Tissue distribution and elimination after oral and intravenous administration of different titanium dioxide nanoparticles in rats, Part. Fibre Toxicol., 11, 30, 10.1186/1743-8977-11-30 · DOI
  28. Godwin, 2015, Nanomaterial categorization for assessing risk potential to facilitate regulatory decision-making, ACS Nano, 9, 3409, 10.1021/acsnano.5b00941 · DOI
  29. Gomez, 2013, Generation of TiO2 aerosols from liquid suspensions: influence of colloid characteristics, Aerosol Sci. Technol., 47, 1383, 10.1080/02786826.2013.845645 · DOI
  30. Gosens, 2016, Organ burden and pulmonary toxicity of nano-sized copper (II) oxide particles after short-term inhalation exposure, Nanotoxicology, 1-12
  31. Graham, 2014, In vivo processing of ceria nanoparticles inside liver: impact on free-radical scavenging activity and oxidative stress, ChemPlusChem, 79, 1083, 10.1002/cplu.201402080 · DOI · Paper page
  32. Graham, 2017, From dose to response: in vivo nanoparticle processing and potential toxicity, Adv. Exp. Med. Biol., 947, 71, 10.1007/978-3-319-47754-1_4 · DOI · Paper page
  33. Gregoratto, 2010, Modelling particle retention in the alveolar-interstitial region of the human lungs, J. Radiol. Prot., 30, 491, 10.1088/0952-4746/30/3/005 · DOI
  34. Guldberg, 1995, Method for determining in-vitro dissolution rates of man-made vitreous fibres, Glastech. Ber. Glass Sci. Technol., 68, 181
  35. Guldberg, 1998, Measurement of in-vitro fibre dissolution rate at acidic ph, Ann. Occup. Hyg., 42, 233, 10.1016/S0003-4878(98)00026-X · DOI
  36. He, 2014, Electron spin resonance spectroscopy for the study of nanomaterial-mediated generation of reactive oxygen species, J. Food Drug Anal., 22, 49, 10.1016/j.jfda.2014.01.004 · DOI
  37. Hellack, 2017, Analytical methods to assess the oxidative potential of nanoparticles: a review, Environ. Sci. Nano, 10.1039/C7EN00346C · DOI
  38. Henderson, 2014, Inter-laboratory validation of bioaccessibility testing for metals, Regul. Toxicol. Pharmacol., 70, 170, 10.1016/j.yrtph.2014.06.021 · DOI
  39. Hendrickson, 2016, Size dependent differences in biodistribution of titanium dioxide nanoparticles after sub-acute intragastric administrations to rats, Curr. Nanosci., 12, 00, 10.2174/1573413711666151008013943 · DOI
  40. Hering, 1995, On-line determination of particle size and density in the nanometer size range, Aerosol Sci. Technol., 23, 155, 10.1080/02786829508965301 · DOI
  41. Heringa, 2016, Risk assessment of titanium dioxide nanoparticles via oral exposure, including toxicokinetic considerations, Nanotoxicology, 1
  42. Hinderliter, 2010, ISDD: a computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies, Part. Fibre Toxicol., 7, 36, 10.1186/1743-8977-7-36 · DOI
  43. Hirn, 2011, Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration, Eur. J. Pharm. Biopharm., 77, 407, 10.1016/j.ejpb.2010.12.029 · DOI
  44. IARC, 2014, Carcinogenicity of fluoro-edenite, silicon carbide fibres and whiskers, and carbon nanotubes, Lancet Oncol., 15, 1427, 10.1016/S1470-2045(14)71109-X · DOI
  45. ICRP, 1994, 66, 1
  46. Ivask, 2017, Complete transformation of ZnO and CuO nanoparticles in culture medium and lymphocyte cells during toxicity testing, Nanotoxicology, 10.1080/17435390.2017.1282049 · DOI
  47. Jang, 2001, Controlled synthesis of titanium dioxide nanoparticles in a modified diffusion flame reactor, Mater. Res. Bull., 36, 627, 10.1016/S0025-5408(01)00552-9 · DOI
  48. Jiang, 2008, Does nanoparticle activity depend upon size and crystal phase?, Nanotoxicology, 2, 33, 10.1080/17435390701882478 · DOI
  49. Kasai, 2015, Thirteen-week study of toxicity of fiber-like multi-walled carbon nanotubes with whole-body inhalation exposure in rats, Nanotoxicology, 9, 413, 10.3109/17435390.2014.933903 · DOI
  50. Kasai, 2016, Lung carcinogenicity of inhaled multi-walled carbon nanotube in rats, Part. Fibre Toxicol., 13, 53, 10.1186/s12989-016-0164-2 · DOI
  51. Keller, 2014, Time course of lung retention and toxicity of inhaled particles: short-term exposure to nano-ceria, Arch. Toxicol., 88, 2033, 10.1007/s00204-014-1349-9 · DOI · Paper page
  52. Konduru, 2014, Biokinetics and effects of barium sulfate nanoparticles, Part. Fibre Toxicol., 11, 55, 10.1186/s12989-014-0055-3 · DOI · Paper page
  53. Konduru, 2015, Silica coating influences the corona and biokinetics of cerium oxide nanoparticles, Part. Fibre Toxicol., 12, 31, 10.1186/s12989-015-0106-4 · DOI
  54. Kreyling, 1990, Interspecies comparison of lung clearance of “insoluble” particles, J. Aerosol Med., 3, s-93, 10.1089/jam.1990.3.Suppl_1.S-93 · DOI
  55. Kreyling, 1990, In vitro dissolution of uniform cobalt oxide particles by human and canine alveolar macrophages, Am. J. Respir. Cell Mol. Biol., 2, 413, 10.1165/ajrcmb/2.5.413 · DOI
  56. Kreyling, 1991, Interspecies comparison of phagolysosomal pH in alveolar macrophages, Inhal. Toxicol., 3, 91, 10.3109/08958379109145276 · DOI
  57. Kreyling, 2014, Air–blood barrier translocation of tracheally instilled gold nanoparticles inversely depends on particle size, ACS Nano, 8, 222, 10.1021/nn403256v · DOI · Paper page
  58. Kreyling, 2017, Quantitative biokinetics of titanium dioxide nanoparticles after intravenous injection in rats (Part 1), Nanotoxicology, 1
  59. Kreyling, 2017, Quantitative biokinetics of titanium dioxide nanoparticles after oral application in rats (Part 2), Nanotoxicology, 1
  60. Kreyling, 2017, Quantitative biokinetics of titanium dioxide nanoparticles after intratracheal instillation in rats (Part 3), Nanotoxicology, 1
  61. Kuhlbusch, 2017, Nanomaterial exposures for worker, consumer and the public, NanoImpact
  62. Lundborg, 1985, Dissolution of metals by human and rabbit alveolar macrophages, Br. J. Ind. Med., 42, 642
  63. Lundborg, 1995, Phagolysosomal morphology and dissolution of cobalt oxide particles by human and rabbit alveolar macrophages, Exp. Lung Res., 21, 51, 10.3109/01902149509031744 · DOI
  64. Maher, 2016, Magnetite pollution nanoparticles in the human brain, Proc. Natl. Acad. Sci. U. S. A., 89, 7683
  65. Ma-Hock, 2009, Inhalation toxicity of multiwall carbon nanotubes in rats exposed for 3 months, Toxicol. Sci., 112, 468, 10.1093/toxsci/kfp146 · DOI · Paper page
  66. Ma-Hock, 2013, Comparative inhalation toxicity of multi-wall carbon nanotubes, graphene, graphite nanoplatelets and low surface carbon black, Part. Fibre Toxicol., 10, 23, 10.1186/1743-8977-10-23 · DOI
  67. Malmgren, 1978, Uptake and retrograde axonal transport of various exogenous macromolecules in normal and crushed hypoglossal nerves, Brain Res., 153, 477, 10.1016/0006-8993(78)90333-5 · DOI
  68. Maricq, 2004, The effective density and fractal dimension of soot particles from premixed flames and motor vehicle exhaust, Aerosol Sci., 35, 1251, 10.1016/j.jaerosci.2004.05.002 · DOI
  69. Methner, 2010, Nanoparticle Emission Assessment Technique (NEAT) for the identification and measurement of potential inhalation exposure to engineered nanomaterials—part B: results from 12 field studies, J. Occup. Environ. Hyg., 7, 163, 10.1080/15459620903508066 · DOI
  70. Meuller, 2012, Review of spark discharge generators for production of nanoparticle aerosols, Aerosol Sci. Technol., 46, 1256, 10.1080/02786826.2012.705448 · DOI
  71. Miller, 2013, Estimating lung burdens based on individual particle density estimated from scanning electron microscopy and cascade impactor samples, Inhal. Toxicol., 25, 813, 10.3109/08958378.2013.850562 · DOI
  72. Miller, 2016, Improvements and additions to multiple path particle dosimetry model, J. Aerosol Sci., 99, 14, 10.1016/j.jaerosci.2016.01.018 · DOI
  73. Morrow, 1992, Contemporary issues in toxicology — dust overloading of the lungs: update and appraisal, Toxicol. Appl. Pharmacol., 113, 1, 10.1016/0041-008X(92)90002-A · DOI
  74. Mortensen, 2008, In vivo skin penetration of quantum dot nanoparticles in the murine model: the effect of UVR, Nano Lett., 8, 2779, 10.1021/nl801323y · DOI
  75. Nel, 2013, A multi-stakeholder perspective on the use of alternative test strategies for nanomaterial safety assessment, ACS Nano, 7, 6422, 10.1021/nn4037927 · DOI · Paper page
  76. Nguyen-Legros, 1981, Evolution du lieu de stockage du dextran-fer transporté par le flux axonal retrograde dans le système nerveux central du rat, Acta Neuropathol., 54, 101, 10.1007/BF00689402 · DOI
  77. Noël, 2013, Generating nano-aerosols from TiO2 (5nm) nanoparticles showing different agglomeration states. application to toxicological studies, J. Occup. Environ. Hyg., 10, 86, 10.1080/15459624.2012.748340 · DOI
  78. Nurkiewicz, 2009, Pulmonary nanoparticle exposure disrupts systemic microvascular nitric oxide signaling, Toxicol. Sci., 110, 191, 10.1093/toxsci/kfp051 · DOI
  79. Nyberg, 1989, Intraphagosomal pH in alveolar macrophages studied with fluorescein-labeled amorphous silica particles, Exp. Lung Res., 15, 49, 10.3109/01902148909069608 · DOI
  80. Nyberg, 1992, Phagolysosomal pH in alveolar macrophages, Environ. Health Perspect., 97, 149, 10.1289/ehp.9297149 · DOI
  81. Oberdörster, 1989, Dosimetric principles for extrapolating results of rat inhalation studies to humans, using nickel as an example, Health Phys., 57, 213, 10.1097/00004032-198907001-00027 · DOI
  82. Oberdorster, 1992, Role of the alveolar macrophage in lung injury: studies with ultrafine particles, Environ. Health Perspect., 97, 193
  83. Oberdörster, 2010, Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology, J. Intern. Med., 267, 89, 10.1111/j.1365-2796.2009.02187.x · DOI
  84. Oberdörster, 2012, Nanotoxicology: in vitro - in vivo dosimetry, EHP Correspondence, 120, A13
  85. Oberdörster, 2005, Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles, EHP, 113, 823, 10.1289/ehp.7339 · DOI · Paper page
  86. Oberdörster, 2015, Inhalation exposure to carbon nanotubes (CNT) and carbon nanofibers (CNF): methodology and dosimetry, J. Toxicol. Environ. Health Part B, 18, 121, 10.1080/10937404.2015.1051611 · DOI · Paper page
  87. Olsson, 1978, A simple histochemical method for double labelling of neurons by retrorade axonal transport, Neurosci. Lett., 8, 265, 10.1016/0304-3940(78)90133-7 · DOI
  88. Olsson, 1981, Neuronal uptake of iron: somatopetal axonal transport and fate of cationized and native ferritin and iron-dextran after intramuscular injections, Neuropathol. Appl. Neurobiol., 7, 85, 10.1111/j.1365-2990.1981.tb00078.x · DOI
  89. Pal, 2014, Screening for oxidative damage by engineered nanomaterials: a comparative evaluation of FRAS and DCFH, J. Nanopart. Res., 16, 2167, 10.1007/s11051-013-2167-3 · DOI
  90. Park, 2003, A closure study of aerosol mass concentration measurements: comparison of values obtained with filters and by direct measurements of mass distributions, Atmos. Environ., 37, 1223, 10.1016/S1352-2310(02)01016-6 · DOI
  91. Pauluhn, 2010, Multi-walled carbon nanotubes (Baytubes): approach for derivation of occupational exposure limit, Regul. Toxicol. Pharmacol., 57, 78, 10.1016/j.yrtph.2009.12.012 · DOI
  92. Pekkanen, 2002, Particulate air pollution and risk of ST-segment depression during repeated submaximal exercise tests among subjects with coronary heart disease. The exposure and risk assessment for fine and ultrafine particles in ambient air (ULTRA) study, Circulation, 106, 933, 10.1161/01.CIR.0000027561.41736.3C · DOI
  93. Potter, 1991, Glass fiber dissolution in a physiological saline solution, Glastech. Ber., 64, 16
  94. Prow, 2011, Nanoparticles and microparticles for skin drug delivery, Adv. Drug Deliv. Rev., 63, 470, 10.1016/j.addr.2011.01.012 · DOI
  95. Riebeling, 2016, A redox proteomics approach to investigate the mode of action of nanomaterials, Toxicol. Appl. Pharmacol., 299, 24, 10.1016/j.taap.2016.01.019 · DOI
  96. Rinderknecht, 2007, Surface functionalization affects the role of nanoparticle disposition, Am. J. Respir. Crit. Care Med., 175, A246
  97. Rushton, 2010, Concept of assessing nanoparticle hazards considering nanoparticle dosemetric and chemical/biological response-metrics, J. Toxicol. Environ. Health A, 73, 445, 10.1080/15287390903489422 · DOI · Paper page
  98. Ryman-Rasmussen, 2009, Inhaled carbon nanotubes reach the subpleural tissue in mice, Nat. Nanotechnol., 4, 747, 10.1038/nnano.2009.305 · DOI
  99. Sayre, 2017, Methods and data for regulatory risk assessment of nanomaterials: questions for an expert consultation, NanoImpact, 8, 20, 10.1016/j.impact.2017.07.001 · DOI
  100. Schleh, 2013, Biodistribution of inhaled gold nanoparticles in mice and the influence of surfactant protein D, J. Aerosol Med. Pulm. Drug Deliv., 26, 24, 10.1089/jamp.2011.0951 · DOI
  101. Sebastian, 2002, test guideline: in-vitro acellular dissolution of man-made vitreous silicate fibres, Glas. Sci. Technol., 75, 263
  102. Shatkin, 2016, Comment on Shvedova et al. (2016), “gender differences in murine pulmonary responses elicited by cellulose nanocrystals”, Part. Fibre Toxicol., 13, 59, 10.1186/s12989-016-0170-4 · DOI
  103. Shi, 2017, The roles of surface chemistry, dissolution rate, and delivered dose in the cytotoxicity of copper nanoparticles, Nanoscale, 9, 4739, 10.1039/C6NR09102D · DOI
  104. Shvedova, 2008, Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, and mutagenesis, Am. J. Physiol. Lung Cell. Mol. Physiol., 295, L552, 10.1152/ajplung.90287.2008 · DOI
  105. Slikker, 2004, Dose-dependent transitions in mechanisms of toxicity, Toxicol. Appl. Pharmacol., 201, 203, 10.1016/j.taap.2004.06.019 · DOI
  106. Snipes, 1983, Retention of monodisperse or polydisperse aluminosilicate particle inhaled by dogs, rats and mice, Toxicol. Appl. Pharmacol., 69, 345, 10.1016/0041-008X(83)90258-2 · DOI
  107. Spencer, 2007, Simultaneous measurement of the effective density and chemical composition of ambient aerosol particles, Environ. Sci. Technol., 41, 1303, 10.1021/es061425+ · DOI
  108. Stapleton, 2012, Impairment of coronary arteriolar endothelium-dependent dilation after multi-walled carbon nanotube inhalation: a time-course study, Int. J. Mol. Sci., 13, 13781, 10.3390/ijms131113781 · DOI
  109. Stefaniak, 2005, Characterization of phagolysosomal simulant fluid for study of beryllium aerosol particle dissolution, Toxicol. in vitro, 19, 123, 10.1016/j.tiv.2004.08.001 · DOI
  110. Stone, 2017, Nanomaterials vs ambient ultrafine particles: an opportunity to exchange toxicology knowledge, Environ. Health Perspect., 10.1289/EHP424 · DOI · Paper page
  111. Sung, 2009, Subchronic inhalation toxicity of silver nanoparticles, Toxicol. Sci., 108, 452, 10.1093/toxsci/kfn246 · DOI
  112. Suzui, 2016, Multiwalled carbon nanotubes intratracheally instilled into the rat lung induce development of pleural malignant mesothelioma and lung tumors, Cancer Sci., 107, 924, 10.1111/cas.12954 · DOI
  113. Tsai, 2009, Characterization and evaluation of nanoparticle release during the synthesis of single-walled and multiwalled carbon nanotubes by chemical vapor deposition, Environ. Sci. Technol., 43, 6017, 10.1021/es900486y · DOI
  114. Utembe, 2015, Dissolution and biodurability: important parameters needed for risk assessment of nanomaterials, Part. Fibre Toxicol., 12, 11, 10.1186/s12989-015-0088-2 · DOI
  115. Wang, 2015, Characteristics of airborne fractal-like agglomerates of carbon nanotubes, Carbon, 93, 441, 10.1016/j.carbon.2015.05.079 · DOI
  116. Warheit, 2005, Comparative pulmonary toxicity inhalation and instillation studies with different TiO2 particle formulations: impact of surface treatments on particle toxicity, Toxicol. Sci., 88, 514, 10.1093/toxsci/kfi331 · DOI
  117. Warheit, 2006, Pulmonary instillation studies with nanoscale TiO2 rods and dots in rats: toxicity is not dependent upon particle size and surface area, Toxicol. Sci., 91, 227, 10.1093/toxsci/kfj140 · DOI
  118. Weldon, 2016, Occupational exposure limit for silver nanoparticles: considerations on the derivation of a general health-based value, Nanotoxicology, 10, 945, 10.3109/17435390.2016.1148793 · DOI
  119. Wohlleben, 2013, Nanospecific guidance in REACH: a comparative physical-chemical characterization of 15 materials with methodical correlations, J. Ceram. Sci. Technol., 04, 93
  120. van der Zande, 2012, Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure, ACS Nano, 6, 7427, 10.1021/nn302649p · DOI
  121. Zareba, 2009, ECG parameters and exposure to carbon ultrafine particles in young healthy subjects, Inhal. Toxicol., 21, 223, 10.1080/08958370802492407 · DOI

Cited by

Sorted by citations

Metadata

Authors
Oberdörster, G., & Kuhlbusch, T. A. J.
Venue
NanoImpact
Publisher
Elsevier BV
Published
2018-04
Volume
10
Pages
38-60
ISSN
2452-0748
DOI
10.1016/j.impact.2017.10.007
Cited by
88
References
6
Language
en
Licence
Funders
EU H2020 (646325)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review